Abstract
During public health crises like the COVID-19 pandemic, ultraviolet-C (UV-C) decontamination of N95 respirators for emergency reuse has been implemented to mitigate shortages. However, decontamination efficacy across N95s is poorly understood, due to the dependence on received UV-C dose, which varies across the complex three-dimensional N95 shape. Robust quantification of UV-C dose across N95 facepieces presents challenges, as few UV-C measurement tools have sufficient 1) small, flexible form factor, and 2) angular response. To address this gap, we combine optical modeling and quantitative photochromic indicator (PCI) dosimetry with viral inactivation assays to generate high-resolution maps of “on-N95” UV-C dose and concomitant SARS-CoV-2 viral inactivation across N95 facepieces within a commercial decontamination chamber. Using modeling to rapidly identify on-N95 locations of interest, in-situ measurements report a 17.4 ± 5.0-fold dose difference across N95 facepieces in the chamber, yielding 2.9 ± 0.2-log variation in SARS-CoV-2 inactivation. UV-C dose at several on-N95 locations was lower than the lowest-dose locations on the chamber floor, highlighting the importance of on-N95 dose validation. Overall, we couple optical simulation with in-situ PCI dosimetry to relate UV-C dose and viral inactivation at specific on-N95 locations, informing the design of safe and effective decontamination protocols.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge the following funding sources: University of California, Berkeley College of Engineering Dean's COVID-19 Emergency Research Fund (PI: A.E.H), Chan Zuckerberg Biohub Investigator Program (PI: A.E.H.), NIH training grant T32GM008155 (A.G. and A.S.), National Defense Science and Engineering Graduate (NDSEG) Fellowship (A.G.), National Science Foundation Graduate Research Fellowship Program (NSF GRFP, A.S.), University of California, Berkeley Siebel Scholarship (A.S.), and the Natural Sciences and Engineering Research Council of Canada (NSERC) postdoctoral fellowship (S.M.G). A.W.R. is an Open Philanthropy Fellow of the Life Sciences Research Foundation. We greatly appreciate the generous donation of the following materials: all UV-C chambers and bulbs (Betty Chang at Spectro-UV), handheld UV point lamp/source (Daniel Tristan at Spectroline), 3M 1860 N95s (Kristen Bole, Dr. Aenor Sawyer, and Dr. Nichole Starr at University of California, San Francisco) and Zemax OpticStudio Professional license (S. Subbiah and David Lineberger).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All study procedures were approved by the UC Berkeley Committee for Laboratory and Environmental Biosafety and conducted in agreement with BSL-3 requirements.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are within the paper and the supplementary material. All reported data are available from the corresponding author upon reasonable request.
